End of the debate about antiretroviral treatment initiation
- PMID: 24602843
- PMCID: PMC4084688
- DOI: 10.1016/S1473-3099(13)70329-3
End of the debate about antiretroviral treatment initiation
Comment in
-
Antiretroviral treatment initiation.Lancet Infect Dis. 2014 Dec;14(12):1175. doi: 10.1016/S1473-3099(14)70947-8. Epub 2014 Nov 17. Lancet Infect Dis. 2014. PMID: 25455976 No abstract available.
-
Antiretroviral treatment initiation.Lancet Infect Dis. 2014 Dec;14(12):1175-6. doi: 10.1016/S1473-3099(14)70951-X. Epub 2014 Nov 17. Lancet Infect Dis. 2014. PMID: 25455977 No abstract available.
-
Antiretroviral treatment initiation--authors' reply.Lancet Infect Dis. 2014 Dec;14(12):1176-7. doi: 10.1016/S1473-3099(14)71005-9. Epub 2014 Nov 17. Lancet Infect Dis. 2014. PMID: 25455978 Free PMC article. No abstract available.
Comment on
-
Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial.Lancet Infect Dis. 2014 Apr;14(4):281-90. doi: 10.1016/S1473-3099(13)70692-3. Epub 2014 Mar 4. Lancet Infect Dis. 2014. PMID: 24602844 Free PMC article. Clinical Trial.
References
-
- Mellors JW, Rinaldo CRJ, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 1996 May;272(5265):1167–70. - PubMed
-
- Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med. 1997 Sep;337(11):725–33. - PubMed
-
- Wood E, Hogg RS, Harrigan PR, Montaner JSG. When to initiate antiretroviral therapy in HIV-1-infected adults: a review for clinicians and patients. Lancet Infect Dis. 2005 Jul;5(7):407–14. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical